FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021648195> ?p ?o ?g. }

• W2021648195 endingPage "2269" @default.
• W2021648195 startingPage "2262" @default.
• W2021648195 abstract "Background and Purpose— NXY-059 is a free radical-trapping neuroprotectant developed for use in acute ischemic stroke. To facilitate prompt administration of treatment, potentially before neuroimaging, we investigated the safety of NXY-059 in patients with intracerebral hemorrhage (ICH). Methods— We randomized 607 patients within 6 hours of acute ICH to receive 2270 mg intravenous NXY-059 over 1 hour and then up to 960 mg/h over 71 hours, or matching placebo, in addition to standard care. The primary outcome was safety: the mortality and the frequency of adverse events, and the change from baseline for a variety of serum, imaging, and electrophysiological measurements. We also studied the overall distribution of disability scores on the modified Rankin Scale (mRS) and the Barthel index. Results— We treated 300 patients with NXY-059 and 303 with placebo. Treatment groups were well matched for prognostic variables including Glasgow Coma Scale, risk factors, and age. The mean National Institute of Health Stroke Scale score on admission was 14 in both groups. The baseline hemorrhage volume was 22.4±20.1 mL in the NXY-059 group and 23.3±22.8 mL in the placebo group (mean±SD). Most hemorrhages were related to hypertension or anticoagulant use. Mortality was similar in both groups: 20.3% for NXY-059 and 19.8% for placebo-treated patients. The proportion of patients who experienced an adverse event was the same for both groups, whereas for serious adverse events the proportion was slightly higher in the NXY-059 group. However, no pattern emerged to indicate a safety concern. Serum potassium fell transiently in both groups, lower in the NXY-059 group. There were no differences in 3-month function, disability, or neurological deficit scores. The odds ratio for an improved outcome in 3-month mRS scores in the NXY-059 group was 1.01 (95% CI 0.75, 1.35). Conclusions— NXY-059 given within 6 hours of acute ICH has a good safety and tolerability profile, with no adverse effect on important clinical outcomes." @default.
• W2021648195 created "2016-06-24" @default.
• W2021648195 creator A5021227220 @default.
• W2021648195 creator A5026886390 @default.
• W2021648195 creator A5029980507 @default.
• W2021648195 creator A5033104412 @default.
• W2021648195 creator A5039358787 @default.
• W2021648195 creator A5041751659 @default.
• W2021648195 creator A5050507154 @default.
• W2021648195 creator A5064086551 @default.
• W2021648195 creator A5069168631 @default.
• W2021648195 creator A5077931624 @default.
• W2021648195 creator A5079574532 @default.
• W2021648195 creator A5080288555 @default.
• W2021648195 creator A5086474167 @default.
• W2021648195 date "2007-08-01" @default.
• W2021648195 modified "2023-10-16" @default.
• W2021648195 title "Safety and Tolerability of NXY-059 for Acute Intracerebral Hemorrhage" @default.
• W2021648195 cites W105751255 @default.
• W2021648195 cites W1513883393 @default.
• W2021648195 cites W1550111394 @default.
• W2021648195 cites W1983429041 @default.
• W2021648195 cites W1986468407 @default.
• W2021648195 cites W1987963401 @default.
• W2021648195 cites W1989118903 @default.
• W2021648195 cites W2001337872 @default.
• W2021648195 cites W2011159396 @default.
• W2021648195 cites W2016293448 @default.
• W2021648195 cites W2016656772 @default.
• W2021648195 cites W205495280 @default.
• W2021648195 cites W2055946117 @default.
• W2021648195 cites W2074463413 @default.
• W2021648195 cites W2085484919 @default.
• W2021648195 cites W2094585602 @default.
• W2021648195 cites W2105534568 @default.
• W2021648195 cites W2127707745 @default.
• W2021648195 cites W2129409167 @default.
• W2021648195 cites W2131659895 @default.
• W2021648195 cites W2132581487 @default.
• W2021648195 cites W2133640401 @default.
• W2021648195 cites W2135637406 @default.
• W2021648195 cites W2137545445 @default.
• W2021648195 cites W2155758555 @default.
• W2021648195 cites W2161910408 @default.
• W2021648195 cites W2189726121 @default.
• W2021648195 cites W2405825064 @default.
• W2021648195 doi "https://doi.org/10.1161/strokeaha.106.472746" @default.
• W2021648195 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17569876" @default.
• W2021648195 hasPublicationYear "2007" @default.
• W2021648195 type Work @default.
• W2021648195 sameAs 2021648195 @default.
• W2021648195 citedByCount "165" @default.
• W2021648195 countsByYear W20216481952012 @default.
• W2021648195 countsByYear W20216481952013 @default.
• W2021648195 countsByYear W20216481952014 @default.
• W2021648195 countsByYear W20216481952015 @default.
• W2021648195 countsByYear W20216481952016 @default.
• W2021648195 countsByYear W20216481952017 @default.
• W2021648195 countsByYear W20216481952018 @default.
• W2021648195 countsByYear W20216481952019 @default.
• W2021648195 countsByYear W20216481952020 @default.
• W2021648195 countsByYear W20216481952021 @default.
• W2021648195 countsByYear W20216481952022 @default.
• W2021648195 countsByYear W20216481952023 @default.
• W2021648195 crossrefType "journal-article" @default.
• W2021648195 hasAuthorship W2021648195A5021227220 @default.
• W2021648195 hasAuthorship W2021648195A5026886390 @default.
• W2021648195 hasAuthorship W2021648195A5029980507 @default.
• W2021648195 hasAuthorship W2021648195A5033104412 @default.
• W2021648195 hasAuthorship W2021648195A5039358787 @default.
• W2021648195 hasAuthorship W2021648195A5041751659 @default.
• W2021648195 hasAuthorship W2021648195A5050507154 @default.
• W2021648195 hasAuthorship W2021648195A5064086551 @default.
• W2021648195 hasAuthorship W2021648195A5069168631 @default.
• W2021648195 hasAuthorship W2021648195A5077931624 @default.
• W2021648195 hasAuthorship W2021648195A5079574532 @default.
• W2021648195 hasAuthorship W2021648195A5080288555 @default.
• W2021648195 hasAuthorship W2021648195A5086474167 @default.
• W2021648195 hasBestOaLocation W20216481951 @default.
• W2021648195 hasConcept C126322002 @default.
• W2021648195 hasConcept C127413603 @default.
• W2021648195 hasConcept C142724271 @default.
• W2021648195 hasConcept C168563851 @default.
• W2021648195 hasConcept C17624336 @default.
• W2021648195 hasConcept C197934379 @default.
• W2021648195 hasConcept C204787440 @default.
• W2021648195 hasConcept C27081682 @default.
• W2021648195 hasConcept C2777094939 @default.
• W2021648195 hasConcept C2778375690 @default.
• W2021648195 hasConcept C2780645631 @default.
• W2021648195 hasConcept C2780931571 @default.
• W2021648195 hasConcept C3020199598 @default.
• W2021648195 hasConcept C42219234 @default.
• W2021648195 hasConcept C541997718 @default.
• W2021648195 hasConcept C71924100 @default.
• W2021648195 hasConcept C78519656 @default.
• W2021648195 hasConceptScore W2021648195C126322002 @default.
• W2021648195 hasConceptScore W2021648195C127413603 @default.

• next